Skip to content

Vitros Immunodiagnostic System

by Johnson & Johnson Clinical Diagnostics, Inc.

510(k) K962919

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

5 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK962919 Date18 Oct 1996ClearedStatusActive

Recalls

5 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-1293-2019 FDA Class II initiated 20 Feb 2019
    • Terminated Z-1292-2019 FDA Class II initiated 20 Feb 2019

    Luminometer Malfunction May Cause Inability to Process MicroWell Assays on VITROS Systems

    • Terminated Z-0923-2012 FDA Unclassified (pre-2012) initiated 24 Aug 2011

    Software defect; Ortho Clinical Diagnostics received complaints of observed results from diluted samples that were reported as <2.39 mIU/mL (IU/L) instead of the correct No Result, which is accompanied by an Invalid Dilution (ID) code. The diluted results were inconsistent with results from the neat (undiluted) sample, which was within the measuring range of 2.39 - 15,000 mIU/mL. OCD's investigation determined it is possible to obtain negatively biased results if samples are diluted and tested on the VITROS ECi/ECiQ System using VITROS Total B-hCG II Reagent Packs, Lots 0484 and above.

    • Terminated Z-0924-2012 FDA Unclassified (pre-2012) initiated 24 Aug 2011

    Software defect; Ortho Clinical Diagnostics received complaints of observed results from diluted samples that were reported as <2.39 mIU/mL (IU/L) instead of the correct No Result, which is accompanied by an Invalid Dilution (ID) code. The diluted results were inconsistent with results from the neat (undiluted) sample, which was within the measuring range of 2.39 - 15,000 mIU/mL. OCD's investigation determined it is possible to obtain negatively biased results if samples are diluted and tested on the VITROS ECi/ECiQ System using VITROS B-hCG II Reagent Packs, Lots 0484 and above.

    • Terminated Z-0137-06 FDA Unclassified (pre-2012) initiated 29 Sep 2005

    When using Vitro ECi Immunodiagnostic System with Vitros Anti-HBc IgM Reagent Packs and Anti-HAV IgM Reagent Packs, results of the 1st of two required re-test replicates may be negtively biased.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KHO
Device Class
Class I
Regulation
21 CFR Part 862.2560
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Johnson & Johnson Clinical Diagnostics, Inc.

See all devices from Johnson & Johnson Clinical Diagnostics, Inc. →